External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home SMA Europe 2022
Roche and Genentech at

SMA Europe 2022

October 21 - October 23
Barcelona, Spain
sma-europe.eu
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
10:40 AM
Duration 15mins Barcelona, Spain
SUNFISH: 3-year efficacy and safety of risdiplam▼ in Type 2 or 3 SMA
A Nascimento, JW Day, N Deconinck, J Kirschner, ES Mazzone, M Oskoui, K Saito, C Vuillerot, G Baranello, O Boespflug-Tanguy, N Goemans, A Kostera-Pruszczyk, L Servais, J Braid, M Gerber, K Gorni, C Martin, RS Scalco, WY Yeung, E Mercuri on behalf of the SUNFISH Working Group
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 15mins Barcelona, Spain
RAINBOWFISH: preliminary efficacy and safety data in risdiplam▼-treated infants with presymptomatic SMA
Laurent Servais, Michelle A Farrar, Dmitry Vlodavets, Edmar Zanoteli, Mohammad Al‑Muhaizea, Richard S Finkel, Leslie Nelson, Alexandra Prufer, Yi Wang, Carolyn Fisher, Marianne Gerber, Ksenija Gorni, Heidemarie Kletzl, Laura Palfreeman, Renata S Scalco, Enrico Bertini, on behalf of the RAINBOWFISH Study Group
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.